<mods:mods xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" version="3.3" xmlns:mods="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><mods:titleInfo><mods:title>STUDY OF THE INFLUENCE OF A TETRAHYDROISOQUINOLINE BROMINE DERIVATIVEON FREE RADICAL OXIDATIVE PROCESSES</mods:title></mods:titleInfo><mods:name type="personal"><mods:namePart type="given">Umarova</mods:namePart><mods:namePart type="family">M.R</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:name type="personal"><mods:namePart type="given">Terenteva</mods:namePart><mods:namePart type="family">E.O</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:name type="personal"><mods:namePart type="given"></mods:namePart><mods:namePart type="family">AzimovaSh.S</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:abstract>The development of novel antileukemic agents requires not only high cytotoxic efficacy but also a clear understanding of their underlying mechanisms of action. Oxidative stress–mediated pathways are frequently implicated in cancer cell death; however, alternative mechanisms may offer therapeutic advantages [1].</mods:abstract><mods:originInfo><mods:dateIssued encoding="iso8601">2026-01-08</mods:dateIssued></mods:originInfo><mods:originInfo><mods:publisher>Center for Tech and Media Research</mods:publisher></mods:originInfo><mods:genre>Maqola</mods:genre></mods:mods>